Concepedia

Sandya L. Ananth

SL

Statistics

Publications

8

Citations

868

H-Index

8

Active since

1998

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

Lunenfeld-Tanenbaum Research Institute

University of Alabama at Birmingham

Mount Sinai Hospital

Sandya L. Ananth is an author at BioCryst Pharmaceuticals (United States) specializing in pharmacology, medicinal chemistry, and life sciences.

Publications per year

1998–2005

8

Publications

8

BCX-1812 (RWJ-270201):  Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Y.S. Babu, Pooran Chand, Shanta Bantia et al. · Journal of Medicinal Chemistry · 2000 · 378 citations · Full text

, , +6

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

Shanta Bantia, Cynthia Parker, Sandya L. Ananth et al. · Antimicrobial Agents and Chemotherapy · 2001 · 148 citations · Full text

, , +15

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)—a novel potent and orally active immunosuppressive agent

Shanta Bantia, Patrick J. Miller, Cynthia Parker et al. · International Immunopharmacology · 2001 · 89 citations

, , +13

Identification of <i>gmhA</i> , a <i>Yersinia pestis</i> Gene Required for Flea Blockage, by Using a <i>Caenorhabditis elegans</i> Biofilm System

Creg Darby, Sandya L. Ananth, B. Joseph Hinnebusch · Infection and Immunity · 2005 · 81 citations · Full text

, , +14

Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777

Shanta Bantia, Sandya L. Ananth, Cynthia Parker et al. · International Immunopharmacology · 2003 · 78 citations

, , +8

1–5 of 8